Overall Survival With Adjuvant mFOLFIRINOX for Pancreatic Cancer

被引：0
|
作者：
Reni, Michele [1 ,3 ]
Macchini, Marina [1 ]
Porcu, Luca [2 ]
机构：
[1] Univ Vita Salute San Raffaele, San Raffaele Sci Inst IRCCS, Pancreas Translat & Clin Res Ctr, Dept Med Oncol, Milan, Italy
[2] Ist Ric Farmacolog Mario Negri IRCCS, Oncol Dept, Methodol Clin Res Lab, Milan, Italy
[3] Univ Vita Salute San Raffaele, Pancreas Translat & ClinicalResearch Ctr, Dept Med Oncol, San Raffaele ScientificInstitute IRCCS, Via Olgettina 60, I-20132 Milan, Italy
来源：
JAMA ONCOLOGY | 2023年 / 9卷 / 03期
关键词：
D O I：
10.1001/jamaoncol.2022.7358
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：435 / 436
页数：2
相关论文
共 50 条
  • [41] Adjuvant osimertinib improves overall survival
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (08) : 504 - 504
  • [42] Chemotherapy treatment with mFOLFIRINOX in elderly patients with advanced pancreatic cancer
    Basbus, L.
    Verzura, A.
    Bradley, D. Gomez
    ANNALS OF ONCOLOGY, 2023, 34 : S126 - S126
  • [43] Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival
    Morganti, A. G.
    Falconi, M.
    Mattiucci, G. C.
    Arcelli, A.
    Bertini, F.
    Farioli, A.
    Guido, A.
    Di Marco, M. C.
    Fuccio, L.
    Alfieri, S.
    Calvo, F. A.
    Maidment, B. W., III
    Miller, R. C.
    Reni, M.
    Macchia, G.
    Deodato, F.
    Cilla, S.
    Di Gioia, G.
    Cellini, F.
    Valentini, V.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S225 - S226
  • [44] Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival
    Alessio G. Morganti
    Francesco Cellini
    Milly Buwenge
    Alessandra Arcelli
    Sergio Alfieri
    Felipe A. Calvo
    Riccardo Casadei
    Savino Cilla
    Francesco Deodato
    Giancarmine Di Gioia
    Mariacristina Di Marco
    Lorenzo Fuccio
    Federica Bertini
    Alessandra Guido
    Joseph M. Herman
    Gabriella Macchia
    Bert W. Maidment
    Robert C. Miller
    Francesco Minni
    Paolo Passoni
    Chiara Valentini
    Alessia Re
    William F. Regine
    Michele Reni
    Massimo Falconi
    Vincenzo Valentini
    Gian Carlo Mattiucci
    BMC Cancer, 19
  • [45] Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival
    Morganti, Alessio G.
    Cellini, Francesco
    Buwenge, Milly
    Arcelli, Alessandra
    Alfieri, Sergio
    Calvo, Felipe A.
    Casadei, Riccardo
    Cilla, Savino
    Deodato, Francesco
    Di Gioia, Giancarmine
    Di Marco, Mariacristina
    Fuccio, Lorenzo
    Bertini, Federica
    Guido, Alessandra
    Herman, Joseph M.
    Macchia, Gabriella
    Maidment, Bert W., III
    Miller, Robert C.
    Minni, Francesco
    Passoni, Paolo
    Valentini, Chiara
    Re, Alessia
    Regine, William F.
    Reni, Michele
    Falconi, Massimo
    Valentini, Vincenzo
    Mattiucci, Gian Carlo
    BMC CANCER, 2019, 19 (1)
  • [46] Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer
    Li, Xujia
    Huang, Jinsheng
    Wang, Fenghua
    Jiang, Qi
    Huang, Lingli
    Li, Shengping
    Guo, Guifang
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [47] Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial
    van Dam, J. L.
    Verkolf, E. M. M.
    Dekker, E. N.
    Bonsing, B. A.
    Bratlie, S. O.
    Brosens, L. A. A.
    Busch, O. R.
    van Driel, L. M. J. W.
    van Eijck, C. H. J.
    Feshtali, S.
    Ghorbani, P.
    de Groot, D. J. A.
    de Groot, J. W. B.
    Haberkorn, B. C. M.
    de Hingh, I. H.
    van der Holt, B.
    Karsten, T. M.
    van der Kolk, M. B.
    Labori, K. J.
    Liem, M. S. L.
    Loosveld, O. J. L.
    Molenaar, I. Q.
    Polee, M. B.
    van Santvoort, H. C.
    de Vos Geelen, J.
    Wumkes, M. L.
    van Tienhoven, G.
    Homs, M. Y. V.
    Besselink, M. G.
    Wilmink, J. W.
    Groot Koerkamp, B.
    BMC CANCER, 2023, 23 (01)
  • [48] Adjuvant chemoradiation to improve survival compared to adjuvant chemotherapy in selected patients with pancreatic cancer
    Kumar, Aryavarta M. S.
    Falk, Gavin
    Stephans, Kevin L.
    Walsh, Matthew
    Pelley, Robert James
    Abdel-Wahab, May
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [49] Resected pancreatic cancer (PC): Impact of adjuvant therapy (Rx) at a high-volume center (HVC) on overall survival (OS).
    Mandelson, Margaret T.
    Picozzi, Vincent J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [50] Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base
    Rutter, Charles E.
    Park, Henry S.
    Corso, Christopher D.
    Lester-Coll, Nataniel H.
    Mancini, Brandon R.
    Yeboa, Debra N.
    Johung, Kimberly L.
    CANCER, 2015, 121 (23) : 4141 - 4149
12345